Dear Fellow Investor,
If you want to know how the coronavirus could be destroyed forever…
…and get a tantalising glimpse of the way the world may look after the crisis is over…
>>>>Then you need to know about an emerging technology so powerful it could help create a‘plug in and play universal vaccine.’
That’s according to researchers at the Singularity University — the research institute co-founded by Ray Kurzweil. (If you’ve never heard of him, Kurzweil is perhaps the world’s most famous inventor. He was once selected by PBS as one of the ‘sixteen revolutionaries who made America’.)
In the pages that follow, you’ll get a first look at this technology…perhaps the most valuable technology ever created.
Don’t take my word for it.
Ask Nobel Prize-winning scientist Professor Craig Mello.
According to The Independent in 2013, he said it’s‘one of those things you have to see to believe. But when I saw it working, my jaw dropped.’
The World Health Organisation and the US military have leapt on the potential. They’re already developing an answer to coronavirus and 39 other strains of influenza.
Bill Gates seems to agree that this breakthrough is a promising weapon in the fight against COVID-19. His foundation has provided significant funding for further research.
And the research wing of the Pentagon — DARPA — has incorporated it into its Pandemic Prevention Platform. The goal is to develop ‘field-ready medical countermeasures within 60 days of isolation of an unknown viral pathogen.’
What makes this breakthrough so powerful?
In short, it isn’t a drug or vaccine in the conventional sense. Nor is it some new high-tech ‘nano-device’.
Instead, it represents a sudden leap forward in our understanding of how diseases actually work…leading to a completely new way of fighting them.
And let’s face it: We NEED new weapons to fight novel viruses.
The tools we have now are relics of the past.
The best we have today is a quarantine…which was first deployed in the 1300s.
We actually get the term ‘quarantine’ from the Italian word for 40 — ‘quaranta’ — which is the number of days new arrivals in medieval Venice had to spend in the lagoon before entering the city.
And even vaccines — which we’re frantically trying to create — are old methods, medically speaking. The first vaccinations were deployed when Napoleon was still an artillery captain in the 1790s.
In other words, we’re fighting COVID-19 with tools that are 200 to 700 years old.
If that sounds absurd to you, that’s because it is.
But that may not be the case for much longer.
This new way of fighting disease is already being described by Wired magazine as ‘the virus killer’ — a tool so powerful that one day vaccinations could become OBSOLETE.
That’s why Bloomberg dubbed it:
To understand why it’s urgent for you to know what’s coming next, you need to hear a remarkable story.
It starts on the 5th of March this year.
The blackest of Thursdays.
For most people, anyway.
In most countries, it was the moment infections went vertical. In response, the stock market nosedived… losing 26% in the next 17 days.
It was an unprecedented fall. As one market veteran put it, according to the AFR:
‘I was broking back in ’87 [during the crash of that year], but this was very different. It’s unlike anything we’ve seen before.’
Amidst the carnage, most people missed the extraordinary events taking place at the UK headquarters of an unknown company called Genedrive.
It’s one of the few pioneers connected to the breakthrough I just told you about.
And because of that connection, something amazing happened…
As the market crashed, Genedrive’s share price held fast. Then, it suddenly took off, jumping 24-fold in 42 days.
For investors who bought the low point on 24 March and sold at the high point 42 days later, that’s enough to turn a $5,000 speculation into $120,000 (excluding trading costs).
Slap-bang in the middle of the worst stock market crash since that which led to the Great Depression.
An emergent technology that grants a ‘God-like power’, in the words of Wired magazine.
As British peer Lord Patel put it in a House of Lords debate in January:
‘As humans, we have been shaped by our discoveries: stone tools, fire and its control, eye glasses, electricity, antibiotics, nuclear physics, organ transplants, in vitro fertilisation and the internet, to name but a few.
‘Yet there is something different—some may say exciting—about [this].’
And Genedrive isn’t an isolated case. Three other connected stocks more than tripled in value in March alone.
As Wired magazine put it, ‘Depending on what kind of person you are, [this] makes you see a gleaming world of the future, a Nobel medallion, or dollar signs.’
But, as incredible as 24-times gains in a few weeks is…
It is not the subject of this report.
Deep down, I’m sure you feel it too.
We’re living through a rare moment in time when the bold have an opportunity to set themselves up forever in just a handful of well-timed moves.
Most people never see these moments coming.
They certainly don’t profit from them.
Because these moments are unconnected to the stuff economists look at, like interest rates, GDP figures or the business cycle.
Instead, they’re driven by TECHNOLOGY.
The first Model T rolled off the factory floor the year after the Panic of 1907 — when the stock market plunged 50% and JP Morgan had to bail out the entire banking system.
Conventional wisdom suggested it was a terrible time to invest.
But that didn’t stop Henry Ford becoming one of the richest men in the world…or the motorcar becoming the defining technology of the early 20th century.
Or how about this game changer...
The microprocessor first emerged in the early 1970s, during the height of the Vietnam War and the cusp of the OPEC oil crisis. But what happened next changed the world — and minted thousands of new millionaires over the decades to come.
Even today, the ongoing effects of this invention continue to filter through society, creating wealth for those that can harness its power.
And in a strange way, the microchip plays a role in the breakthrough we’re talking about today. More on that soon.
The point is this…
By the time most people understood how important these technologies were, the opportunity had passed.
It was already in the pockets of the handful of visionaries who saw…understood…and acted.
But that’s the whole point. To turn a world-changing technology into a life-changing profit, you need two things:
Do both of these things and it’s possible to create the kind of wealth that means your great-great-great-grandchildren are still thanking you a century from now.
And THAT idea is what this report is all about.
Most people find this kind of thinking impossible.
It’s why the Model T and the microprocessor (and countless other breakthroughs) only made a small number of people rich.
It’s why a tiny number of people made money from Genedrive in March. You’d have had to know where to look — and time your move perfectly to buy before the price rise, and get out at the top.
But understand what’s really happening right now — while almost no-one else does — and you’ll see…
Let’s get into the nuts and bolts of it now…
At its core, we’re talking about a new technology.
One that, thanks to its extraordinary potential, is being propelled from the fringes of emerging science to the very heart of the fight against the pandemic.
And as I said, it could hold the key to defeating the coronavirus forever, along with every other virus in its wake.
In the words of Stanford University PhD candidate Tim Abbott in 2018, ‘All you would have to do is change one simple part, and then, boom, you’re actually protected against this new novel virus.’
Meaning, we may never face another pandemic again.
I know how incredible that sounds...
Yet many experts believe it’s possible, thanks to this technology.
It has already been approved for use by the FDA — the US government’s medical regulator.
But this ‘gift from Mother Nature’ (as one Stanford university scientist put it in 2018) has THOUSANDS of potential uses.
Legendary newsman Dan Rather, who hosted CBS Evening News for 24 years, recently described the potential like this (emphasis mine):
‘I’ve covered some of the biggest stories of our age, but this is the biggest.
‘This is something you need to know about. All of you.
‘If you are worried about your health or the health of your children.
‘If you are in finance, law or the world of tech. This will shape ALL of it.’
It’s already been used to reverse blindness…stop cancer cells from multiplying…make people immune to AIDS…and even treat heart disease with a ‘one-off’ injection.
According to researchers at the University of Arizona, it promises to cure 6,000 terrible diseases.
At its core is an innovation that’s ‘almost as fundamental as the transistor’, according to Andrew May, chief scientific officer of one of the first start-ups dedicated to it.
And just like the transistor, I believe it could spawn thousands of new companies…create millions of jobs…and, if history is anything to go by, create many new millionaires…
One CEO even forecast it could one day replace the transistor as the cornerstone of the world economy…and predicts it’ll be worth 25% of the world economy.
Given the world GPD was $86 trillion last year, that’s roughly $20 trillion PER YEAR.
To put that into context, that’s enough money to buy Apple, Microsoft, Google, Facebook, Tesla and Netflix…with enough money left over to buy every property in Sydney.
It’s roughly 337,000% bigger than the industry is today…
When the transistor spawned the modern computing industry, it created the kinds of opportunities that lead to monumental wealth for buy-and-hold investors.
It sent Intel’s share price on a 27,900% rise since 1971…Microsoft by 73,900% since 1986…and Apple by 29,900% since 1976.
IBM soared a frankly mind-bending 6,399,900% since 1947.
That’s right…nearly six-and-a-half MILLION percent (all calculated to 2016).
Will we see a repeat of those kinds of gains in the future?
I’m not saying we will, but the long-term potential is certainly here.
So, I wouldn’t bet against it.
But frankly, when it comes to something this big, it’s pointless trying to pin a forecast down.
With individual early-stage tech stocks, the long-range potential is just too great to boil down to a single number.
But in a second, I’ll show you the stocks I’ve found.
Five stocks, in particular.
You’ll see exactly why I’m so excited about them…
You’ll see how all of them aim to bring about a step-change in how we fight diseases like COVID-19 (in fact, one of these stocks has such potential, it already has deals with 21 of the world’s top 25 pharma companies).
And you’ll see why they could be perfectly placed to not only soar out of the crisis, but for the next decade or more…
I know that might feel counterintuitive.
After all, aren’t we meant to be on the cusp of a global depression?
But here’s what you need to understand…
Major economic crises like this are actually the ‘seedbed’ of new waves of innovation…progress…and rapid wealth creation.
The ‘Long Depression’ of the 1870s led to the creation of the light bulb…steam turbine…radio…the refrigerator…and the telephone.
The Great Depression led to the commercialisation of the radio, the first helicopter, nylon, synthetic rubber…and the first real televisions.
The economic historian Alexander Field calls the 1930s the ‘most technologically progressive’ decade of the 20th century.
These are exactly the moments when daring investors and entrepreneurs can take a risk on a new idea — and potentially make a killing in the process.
If you think about it, it actually makes sense. Times of adversity are when the lazy or slow are exposed, and the creative forward thinkers rewarded.
As Warren Buffett famously said:
‘Only when the tide goes out do you discover who’s been swimming naked.’
Michael J. Cullen’s story is a great example of that in action…
He quit his job right as the Great Depression began and launched a new venture — the first modern supermarket. It was built around technological advancements like the fridge and the car.
Within two years, he was making the equivalent of $75 million.
Then you have J. Paul Getty. In 1930, he took his entire inheritance and bet big on the fuel of the 20th century — oil. As the market took off in the years that followed, he became a billionaire.
In fact, at least seven ‘billion-dollar’ families owe their fortunes to young businesses started in the Great Depression.
It’s been true in recent times, too. Alibaba emerged as a major force right after the SARS outbreak of 2003, becoming the biggest IPO in history (at the time) in 2014.
The same is true of 2008. The global financial crisis crushed the global economy…but it spurred innovation and wealth creation on a scale rarely seen before.
Think of a company like Uber. It was founded in 2009 in the pit of the crisis. In 2011, it was already worth $60 million.
By 2015, it had grown 83,233%.
Or Airbnb. It was founded in 2008 — as the banking system imploded. Yet that didn’t stop it… In fact, its growth went exponential almost immediately, as the chart to the right shows.
In other words:
You see, there are seminal moments in the history of investing...
Moments when new innovations change everything about how human society functions.
Like when Gordon Moore pinpointed ‘Moore’s Law’ (the doubling of computer processing power every 18 months)…or the decoding of the human genome…or the birth of the US military’s ARPANET, which evolved into the modern-day internet…moments that truly change everything.
But, unfortunately, most people never understand what's happening…until it’s too late.
They don’t see or understand the hidden forces that are growing, just under the surface…which, like a tidal wave, are going to completely overwhelm everything that stands in their way.
One of those moments occurred recently, when scientists discovered they could ‘code’ a living cell in the same way we code a computer chip.
This is actually the logical conclusion of a trend that’s been changing the world for nearly half a century.
Think of how many companies and entire industries exist solely because we can code information onto a silicon computer chip.
Microsoft…Amazon…Apple…Intel…IBM…Facebook…even things like bitcoin…they’re all built on code.
Now, an emerging industry is taking that work in a new direction, using the ‘source code’ of all life…DNA.
Thanks to a series of breakthroughs in recent years, we can now edit, correct and even create genetic code as easily as you’d make changes to a Word document.
This isn’t just a simple advance in the world of biology. This is a radical step shift in the entire way we’ve done biology for centuries.
It’s akin to the moment Einstein’s theory of relativity made Newtonian physics obsolete overnight. It’s that big.
There are many ways of coding DNA. We’re discovering new ones all the time.
But they all form part of one emergent phenomenon.
In the words of Forbes commentator John Cumbers recently, it could ‘enable us to synthesize food from thin air, store all the world’s data in a teaspoon of DNA, design smart medicines for individual patients, and program matter itself.’
Keep in mind: This is a field that’s in its infancy right now. Most people have never heard of it or don’t understand it.
And if I’m right, it could change everything.
A company called Sherlock Biosciences found a way to ‘code’ a molecule to search for the virus in the body, using the new gene editing tool CRISPR.
If the cell finds evidence of COVID-19, it releases a signal that can be detected.
As the CEO of the company behind the breakthrough said, it’s ‘addressing one of the greatest healthcare issues to emerge in our lifetime.’
This isn’t just a ‘potential’. It has already been approved for use by the US Food and Drug Administration (FDA).
It’s just one use of many.
Just think about everything we can do with a silicon computer chip. Think of the endless possibilities, opportunities and businesses it has spawned.
The same applies here. Once you’re able to ‘code’ life at the genetic level — to create, edit or correct DNA — you can effectively teach living materials to become smarter, stronger and healthier
In doing so, you open up a vast array of new possibilities…
A company called Synthetic Genomics is working on this one — creating a machine that can put vaccines together as quickly as coders build new websites.
Usually it takes months to build and ship vaccines out to people. Very soon, this could all be done in as little as a day, on demand.
Imagine you could teach cells to ‘record’ biologic events taking place — stuff like interactions with viruses, antibiotics, nutrients and light.
Doctors would literally have an ‘inside view’ of the body on a cellular level. As incredible as it sounds, Harvard scientists are creating this molecular tool — known as CAMERA — as we speak.
It’s the same principle…
Once you understand a superbug in terms of its fundamental source code, you can trigger self-destructive mechanisms.
It’s like finding a ‘Control-Alt-Delete’ shortcut within the deadly bug’s DNA.
Many deadly pathogens like Ebola and Zika are considered ‘incurable’ using existing techniques. But scientists at Harvard and MIT’s Broad Institute have explored ways to use new techniques to teach cells to ‘search and destroy’ these viruses.
Remember, DNA is the ‘source code’ for all life. Not just humans. Viruses…deadly pathogens…even cancer…it all exists because of its DNA.
Once you can change that code, you open scores of new possibilities. Like the researchers who isolated the ‘command centre’ within cancer (known as the hybrid fusion). Then they changed the code to destroy it. (This is being tested as we speak, on both prostate and liver cancer.)
Why does heart disease hit one in 500 people — killing millions each year?
The answer lies — as you’d expect — in the code.
DNA and the genome hold all the answers to any question you might ask. Including heart disease.
Once you can manipulate that code, you can isolate the parts that cause heart disease — and change them.
According to The Guardian, scientists have already proved that’s possible. Researchers found the gene that causes heart disease (known as the MYBPC3 gene) — and edited it out.
It’s the same story, over and over…
Coding cells to make them smarter, stronger and better — and changing the way we fight diseases that kill millions every year.
Remember: The first gene-editing tools are already approved for use against COVID-19.
They’re being deployed as we speak.
And they may even help to save the life of someone you know or love.
That will be your first experience.
I believe that in only a few years…this will be everywhere.
DNA sequencing will be a fact of life…new drugs will be ‘coded’ using DNA…drug development will be accelerated using AI and synthetic biology…we’ll discover new cures for diseases we now consider a death sentence…and pandemics like this will be a thing of the past…
In fact, we’ve known this was coming for years…
Ray Kurzweil — the famous futurist we mentioned earlier — actually forecast this back in his 2005 book, The Singularity Is Near:
‘By understanding the information processes underlying life, we are starting to learn to reprogram our biology to achieve the virtual elimination of disease, dramatic expansion of human potential, and radical life extension.’
Why do I believe this is inevitable?
Well, look around you and you’ll see it’s already well underway…
For starters, governments everywhere are preparing themselves for it to be a big part of our lives.
Nearly every major nation is now creating a kind of ‘library’ of genetic code…which will likely hold the key to many new breakthroughs.
France is sequencing 235,000 genomes…the UK 100,000…China 100,000…Turkey 100,000…Saudi Arabia 10,000…the USA is compiling a million datasets.
Then you have the companies already moving into the industry…
IBM has launched a whole new business dedicated to it.
Google has built a tool called DeepVariant that uses deep learning to scan genetic code for new insights.
Microsoft has paired with a small UK company called Oxford Biomedica to find new uses.
Apple has even begun offering genome mapping to all its employees in Silicon Valley.
And in recent years, there’s been what Scientific American called a ‘gold rush’, with big players like Novartis and AstraZeneca snapping up small companies pioneering gene-editing and other synthetic biology tools.
Take Genedrive, the company I told you about earlier. It soared 24 times off the back of reports its RNA coronavirus testing kit was close to production.
Or UK biotech stock Tiziana Life Sciences. In March, it announced a potential treatment for certain respiratory failure patients. (Its share price trebled in 13 days on the back of the news.)
Some investors are already making it to the investing super leagues.
Check out this article I recently read in Time magazine:
As history tells us, when moments like these come along…you just have to grasp them.
And that’s exactly what I want to help you try and do, starting today…
My name is Ryan Dinse.
I’m not a scientist, doctor or engineer.
I’m an investment analyst. Though, not your typical investment analyst.
I help people understand how their world is about to change — often in sudden and irreversible ways.
And then I show them how I believe you can capitalise on what’s coming by getting in early on stocks positioned at the heart of these exponential trends.
To do this, I work for a pretty unusual financial publishing firm, based in Melbourne, called Port Phillip Publishing.
You may’ve never heard of us before. Not many people have. We like it that way. We don’t advertise in the newspaper or on the TV. And we reserve our research for Australian stock investors who want independent, alternative ideas…insights…and stock market opportunities.
I try to stay modest. But I reckon we do a pretty good job of it.
For instance, in the last couple of years, investors who bought at the lows and sold at the highs could have doubled their money on six different stocks I picked.
In another instance, investors could have made four times their money in less than a year.
Do I get it right every time? No. No one does. And when it comes to early-stage technology companies, it’s impossible to avoid taking some losses. Investors can lose some or all of their money. Those are the risks. The question is, are the potential rewards worth it?
In my view, YES. Consider…
I managed to bag a 496% gain on one stock, right before the corona-crash hit the markets. And in early May, while the world was transfixed on oil prices going negative, I made 123% in a single day on one stock.
It’s a far cry from my old career…
For seven years, I was a financial adviser for a big Melbourne-based institution.
I had $150 million in funds under management on my client book and more than 600 clients.
Working for this giant institution for seven years, I came to understand how fund managers picked and organised their share portfolios.
But to me it seemed like a poor process.
So many rules and restrictions.
We were not permitted to chase new ideas.
We were actively forbidden from pursuing exponential growth.
It seemed crazy to me.
Worse. It smacked of a lack of ambition.
Anything revolutionary…anything radical…anything paradigm shifting…
It was all off limits.
Despite the fact it is precisely THESE ideas that can potentially make investors the most money.
Do they all come off?
No, of course not.
That’s the whole point. It’s what so many people get so wrong about the stock market.
They fear risk.
They wait and wait…delay…and hang on for that ‘sure thing’.
But it never comes along.
This is the real reason the vast majority of investors miss out on some of the biggest gains the stock market has to offer.
If you have an appetite for risk, and want to give yourself an honest shot at tapping into the true potential of the stock market, you have to invest where the most wealth is created.
I believe that that means revolutionary new businesses.
Think about it. Where have the biggest gains come from in the market in recent decades? Not from established businesses that maintain the status quo. No — they’ve come from disruptive new ideas, business models and technology emerging from the fringe.
Almost no one outside of Silicon Valley had heard of Amazon when it IPO’d in 1997. But a $100 stake would have turned into $129,186 by February of 2020.
The same was true of Netflix. How many people do you know who bought it back in 2002? Yet over roughly the next 18 years, it soared 34,340%.
Then you have the really fringe stuff…like bitcoin. In May 2010, one bitcoin cost just 0.0025 cents.
You could buy 10,000 of them for US$25. Then the price went ballistic…soaring to $20,000 (although it has been quite volatile since).
That $25 stake would now be worth roughly $90 million.
Gains like that sound unbelievable. But that’s how new technology works. It emerges on the fringes. Very few know about it. It can be highly speculative and risky. The trick is understanding what’s happening before the mainstream does.
The question is:
Exactly how much money is on the table?
Well, Forbes columnist John Cumbers tried to calculate the long-range potential.
As he put it:
‘If you think back to the 1960s, when we were just inventing the transistor and then going through the history of Silicon Valley, the microprocessor, the Internet, the Web — now 25 percent of the worldwide economy is built on that technology.
‘It’s difficult to say the timeline, but let’s say in the next 25 years, the biology stack and the amount of value that’s built on top of it will definitely be more than 25 percent of the worldwide economy.’
25% of the world economy is US$20 trillion a year.
Yet in 2019, the market size of this industry was just $5.3 billion, according to BCC Research.
That’s a potential 377,258% growth rate.
So how can you tap into potential growth like that?
I have good news on that front.
The companies bringing this world about are — overwhelmingly — small, unknown and absolutely ripe with potential.
Many of them have partnerships with major pharma firms. (For instance, in a second I’ll introduce you to one stock that has inked deals with 21 out of the world’s top 25 pharma companies.)
I believe that some of these small companies could one day go on to become the Apples, Intels and Googles of the next generation — of that I have no doubt.
And right now, you can scoop them up for cents on the dollar.
It’s an incredibly exciting time.
Australia isn’t exactly the first place that jumps to mind when you think of small biotech stocks, is it?
As a result, a lot of people end up seeing this as a ‘foreign stocks only’ story.
Yes, this is an international industry.
It’s developing across every continent…with exciting new opportunities emerging in America…Britain…Europe…Japan…Asia…
And yes, right here too.
In fact, the Australian biotech industry has seen a renaissance in recent years.
Take one bellwether of the Australian biotech industry as a whole — the BDI-40 index. It’s an index of 40 related stocks with market caps beneath $10 billion.
In the 11 years after the financial crisis, it soared 782%.
According to the financial website Stockhead:
‘Its collective market cap skyrocketed in the past 13 years from $2.1 billion to $18.4b.
‘The ASX 200, meanwhile, has largely treaded water.’
Zoom in a little, and some ASX-listed stocks are even more eye-catching...
For example, Paradigm Biopharmaceuticals Ltd [ASX:PAR] grew 14 times in two years. And Volpara Health Technologies Ltd [ASX:VHT] grew six times in two years.
And another stock, Polynovo Ltd [ASX:PNV], rose 98 times in 10 years.
Right here in Australia.
Of course, not all biotech stocks rose like these. Some, in fact, amounted to nothing. But you can certainly see the performance of those that took off.
Which stocks do I believe are most likely to follow in Polynovo’s footsteps?
What if we could find a way to teach our bodies to become immune to COVID-19 — without ever risking infection?
That’s exactly what my first stock recommendation is seeking to do.
It does this in a very unusual way.
See, most ‘traditional’ vaccines work by introducing a small amount of an existing virus into your system.
The idea is that a small, controlled exposure helps your body learn to fight the virus.
It’s the way vaccination has worked for centuries, since Edward Jenner experimented with the first smallpox vaccines. As you may well know, Jennings discovered that a mild dose of cowpox also led to immunity to smallpox.
But that was more than 200 years ago.
As you’ve seen today, the fight against COVID-19 is being led by a new field of medicine… Indeed, a new industry.
That’s where my pick comes in. It’s a small firm that stands a chance of creating the first approved vaccine for COVID-19.
By using something called an ‘RNA vaccine’.
Just as a new piece of software teaches a computer to do something new — run a new program or application — manipulating RNA can ‘teach’ your body to create antibodies to fight COVID-19.
It’s cutting-edge stuff.
In fact, there are no approved RNA vaccines right now.
But this one could be the first.
It’d be a monumental step forward both in medical terms and the fight against COVID-19.
There are no guarantees with something as new as this, of course. But I see signs that make me confident. This company already has a partnership with pharma giant Pfizer.
Even better, its clinical trials are already underway.
It’s one of the world’s best hopes for ending this pandemic for good.
And it may well make the critical breakthrough in the coming months. If it does…expect this company’s share price to go vertical.
In fact, its share price briefly tripled in the space of a week in mid-March.
Luckily for us, it has moved lower since then. But how long it’ll trade this low…I don’t know.
That’s why I’d urge you to get my full write-up on this stock immediately. Then you’ll have everything you need to decide if you want in on this.
I’ve put everything you need to know about it in a password-protected research report. I’d like to send you a copy today. It’s called ‘The Last Pandemic: My Two Favourite Stocks in the Fight Against COVID-19’.
I’ll show you how to grab a copy in a second.
But first, as the name suggests, this isn’t the only stock I’m watching right now…
28 February 1953.
A man walks into a pub in Cambridge and proclaims he’s discovered ‘the secret to life’.
His name is Francis Crick.
The pub was The Eagle, a stone’s throw from Corpus Christi College.
The pub is still there today. On any given day, you’ll find a fair number of tourists enjoying a pint and a bite to eat at the site of one of science’s great discoveries: The ‘double helix’ structure of DNA.
It won Crick and his partner James Watson the Nobel Prize.
And it’s the basis of everything you’ve seen today.
‘I think DNA is going to be the most important material of the 21st century,’ says Emily Leproust, CEO of Twist Bioscience, in 2017. ‘The last century was about computers, and now we are entering an era of biology.’
Imagine we could gene DNA to teach cells to behave in certain ways…make them smarter…stronger…or put them to work fighting disease…
THAT is the future the first stock I have for you today is helping to bring about.
It’s a stock I’m incredibly excited about right now.
And once you understand what this unknown little company is doing…you’ll see why.
This tiny little outfit has built a software platform that can create new ‘smart’ variants of living proteins.
It can create very specific new proteins that are ‘programmed’ to behave in a certain way.
Think of a collision between computer software and a living cell.
That’s what we’re talking about here.
That’s why 21 of the world’s top 25 big pharma companies are working with it.
That includes Glaxo, Merck and Novartis.
If there’s one stock in the world I’d back in the emergence of ‘smart cell tech”’ — it’s this.
But look, I can’t reveal details in this public forum.
This stock is small and volatile. And with that comes risk. You can lose some or all of your investment. It can make massive moves up and down in the blink of an eye. It’s a fraction of the size of its bigger partners like Glaxo.
At the time of writing, it’s the kind of stock even most financial analysts haven’t heard of.
You can only find traces of it on AI and biotech trading forums.
As such, giving even the slightest details here would risk blowing this stock up and killing the opportunity for my subscribers.
That’s why I’ve put everything you need to know about it in the password-protected research report I told you about, titled ‘The Last Pandemic: My Two Favourite Stocks in the Fight Against COVID-19’.
Like I said, it’s yours today. I’ll show you how to download a copy in a second.
And here’s the best part: Because of the recent market downturn, you can buy into this stock at prices you may never see again. It’s a great time to make your move.
That’s why it’s critical I get this report into your hands as quickly as possible.
But as I said earlier, a new opportunity like this is bigger than any one stock. This is really just the beginning. If you want to truly capitalise, there’s much more you need to do…
Which is why I’m also going to show you how to take advantage of…
Think about the sheer variety of different ventures connected to the rise of the microprocessor. Amazon…Uber…Apple…Netflix…Spotify…even digital currencies like bitcoin and Ethereum.
They’re all different kinds of businesses (or currencies). They do different things.
Exactly the same principle applies to sin-biology companies.
Right now, the vast majority of these companies are unknown, just as most tech stocks were in the 1990s. It will unlikely stay that way for long.
That’s why right now is the perfect time to make a few careful moves to claim early stakes in the companies that could be the Google, Amazon or Netflix of this new industry.
A second report I’ve prepared will help you do exactly that.
It contains a full write-up on four specific businesses that I strongly recommend you consider.
It already has approval for use in multiple countries — and is close to FDA approval in the USA.
The stock has already doubled investors’ money since I found it — and there is a lot more to come.
The company has signed five significant new deals in 2020 alone — right through the middle of the pandemic.
In 2019, its share price soared by more than 300%.
Because of the recent stock market downturn, you have the chance to own these businesses at a price you might never see again. And, if the respective companies take off as I expect, you have the chance to make a fortune in the years to come.
Everything you need to know is in a second report I’ve prepared for you today. It’s called ‘Four Ways to Play the Biggest Medical Revolution of the 21stt Century’.
These stocks are speculative and risky. They all have the potential to soar. But that enormous potential comes with risks attached.
Some early-stage tech companies fail. Know that going in. If things don’t go our way, you could lose some or all of your investment. So never invest more than you are prepared to lose.
However, if you are prepared to take the risk…stick with me.
The two reports I’ve just told you about will get you up to speed quickly on this trend.
These are the first two things I want to send you when you take a subscription (with a 30-day trial period) to my firm’s top-rated stock research service, called: Exponential Stock Investor.
As the name suggests, this is a stock investing advisory dedicated to finding — and profiting from — exponential new trends. A lot of the time, that involves trying to understand the impacts of paradigm-shifting new technologies, well before most in the market.
But exponential trends can form in many different ways and we’re constantly on the lookout for any ideas that emerge from the flux of change.
Thinking exponentially doesn’t come easy to most people. We’re programmed to think in linear terms.
The chart to the right highlights why that’s such a big problem.
The red line represents how many people think of growth.
Slow. Steady. Predictable.
But it’s the green line that potentially makes fortunes.
That said, the very fact you’re reading this letter right now tells me you’re one of the few people who CAN think ‘exponentially’.
And it tells me you’ll love Exponential Stock Investor.
Once a month, I publish a special report detailing a new exponential technology that could both change the world and deliver colossal long-term returns.
That’s my mission. I think I do a pretty good job.
But you don’t have to take my word for it.
That’s the great part of my work. Normally, to access my work (we publish 12 investment recommendation reports each year — one per month), it costs $149 per year.
Even at that price, it’s a steal, compared to the amazing investment our firm puts into research each year, and the returns we’ve been able to help some of our customers gain access to.
But today, you can try our work with absolutely no ongoing obligation and at a huge discount to the normal price.
I’ll show you how much you can save in a second. But first, I want to share another special bonus you’ll qualify for if you take me up on this offer.
On New Year’s Eve 2009, a little start-up called Airbnb.com had 1,400 guests booked in to stay for the night.
One year later, on this same night, the number had grown to 6,000 people.
In 2011, there were 31,000 booked through Airbnb on New Year’s Eve.
And the year after that, it tripled to just under 100,000 people.
Then it doubled the next year. Then doubled again. And the same the year after that…
Check out the chart below:
You can see the hockey stick shape this kind of growth creates.
This is the power of exponential investing.
The goal of Exponential Stock Investor, lofty as it may be, is for the chart of every stock we buy to look like this!
Can that be done?
Certainly not with every stock play. That’s highly unrealistic.
But certainly with some.
So, how do you search out unknown stocks with a realistic shot at hockey stick growth?
You need to follow a carefully constructed system.
In this report, you’ll discover how I think you can make the most of this service and invest the same way the world’s smartest early-stage investors do.
I call it the 2-3-5 Strategy.
I’ve been analysing small-cap stocks for almost two decades now. And I’ve made every mistake in the book!
This report shows the results of this vast experience to hopefully help you avoid making those mistakes, and how to build a portfolio of stocks with exponential potential.
The key points are highlighted in full in this report.
It’s yours if you join me today.
And remember, I’ll send you every report I’ve mentioned here as soon as you start your subscription to Exponential Stock Investor.
To recap, here’s everything you’ll get as part of this introductory offer we’ve assembled:
Best of all, you can access all of this work with no ongoing obligation at a 50% discount off the normal rate. Remember, the regular price is $149.
But today, you’ll pay just $69.
Why so cheap?
It is critical you understand how the companies at the forefront of this technological leap forward are going to change the world. They’re emerging now, as you’ve seen. The pandemic makes it even more urgent that you understand both the science and the opportunity.
I don’t want price to be an issue here. So I’ve made sure that it isn’t.
Given everything you’ll get, $69 is an absolute steal.
Keep in mind: This offer also comes with a 30-day money-back guarantee.
If you don’t like what you see, just contact my customer service team within the next 30 days and they’ll refund every cent of that $69.
Keep the reports I’ve sent you. They’re yours.
Given that, there really is no good reason not to give this a shot today.
By the way, that guarantee is 100% backed by my publisher, Port Philip Publishing.
We’ve been in this business for a decade and a half. And I’ll tell you — extraordinary times like today are when our business thrives the most. It’s when huge numbers of new people turn to us for answers, insights and advice.
Well, for starters, we have a great track record of helping people like you understand and profit from sudden and radical change.
Just look at our track record…
Fast forward to today — now there’s a new technology that’s about to change the world.
It might change it more than anything else that’s come before.
It’s emerging now.
I want to help you profit from it.
And that’s what this offer is all about: Your shot at seeding your money in perhaps the most important new industry of the next 50 years.
Now is the time to make your move.
Remember what you’ve seen today:
You absolutely must understand this in order to protect and grow your wealth in the years to come.
My best advice is simple: Make sure you are on the right side of this trend.
Today I’ve made it very easy for you to take the first, necessary steps.
You’ll pay just $69 to receive everything I’ve described here.
If you don’t agree with me that this is the absolute best deal in the financial world, simply let my customer service team know in the first 30 days, and they’ll refund your $69 payment.
What’s coming can’t be stopped.
The question is: Will you be a part of it…or not?
Click the ‘Order Now’ button below, which will take you to a secure order form.
There, you can review the details of this special offer once more, before submitting your order. You’ll get access to all of our critical research reports — everything I’ve described here — in a matter of minutes.
(You can review your order before it’s final)
Though I’ve done my best to lay everything out for you in detail, you might still have questions. So I’ve done my best to anticipate and answer them below…
My goal in Exponential Stock Investor is very simple. It’s to help you invest successfully in the most exciting emerging tech stocks in the world.
This is the kind of stuff most people never get to hear about until it’s far too late. My mission is to get you ahead of the curve and give you a shot at getting in early on the next big tech stock success.
I’ve developed this FAQs section because I believe in accountability, honesty and transparency — about what I do and how I do it.
Please have a read.
I’m sure it will address any concerns you have.
If there’s still something you’d like to know, please send an email to firstname.lastname@example.org.
Let’s run over this again — because you’re seconds away from unlocking a LOT of very valuable (and potentially lucrative) research.
First up, you’ll get your critical briefing: ‘The Last Pandemic: My Two Favourite Stocks in the Fight Against COVID-19’.
You’ll get the names of these stocks…their ticker symbols…and a full write-up on why I’m so excited. You’ll also get my analysis of the risks involved.
You will also get copies of these bonus reports:
In addition, you get a 30-day, no-obligation trial period with your subscription to my investment newsletter, Exponential Stock Investor.
Oh — and I almost forgot.
I have some exciting NEW stock picks coming up in the months ahead. There are several stocks I have my eye on now. With prices much lower than they were at the start of the year, I think this is a buyers’ market — IF you’re selective.
You’ll get these new picks the second they’re released.
No. I’m real. My publisher is real. We’re part of a publishing group that’s been around since 1979. We have countless five-star reviews on Google and a 4.2-star overall rating.
Our business is regulated in Australia by ASIC. I am a fully accredited stock analyst, which means I’m able to give general investment advice in Australia.
Some people will no doubt be wondering if Exponential Stock Investor is a ‘pump and dump’ scheme…or whether I’m ‘front-running’ stocks.
No. Absolutely not.
Quite aside from the fact that I have professional integrity, it is completely against the rules for me to invest in any of the companies I recommend.
If I did that, my employment would be terminated, and I could end up in prison.
I get that people are sceptical. If you are, please read my newsletter over the next month as part of your subscription.
You’ll quickly see that this is the real deal.
No one can guarantee you success in the markets. If someone offers you this, run a mile. There are no guarantees with any form of investing. No one can see the future. And early-stage tech companies are high risk.
You could lose money. Be sure you’re comfortable with that. If you want to be in the running to make big money from the winners, you have to be comfortable with that risk.
The stock market is uncertain. That’s because LIFE is uncertain. No one can see the future. That’s why you should never invest more than you can safely afford to lose.
All I can do is provide the best defence against that uncertainty: Meticulous research.
I know an awful lot about the companies I recommend. I spend pretty much all day, every day, researching and writing about them. It’s an obsession as well as a profession.
And I obsessively monitor every new development in their story.
Of course, I can guarantee you that if you don’t like what you see, for any reason, you can walk away with a full refund of your subscription cost any time in your first 30 days.
My goal is to find the emerging tech companies with the best prospects. I do my best to find opportunities right here in Australia. But if I see something compelling abroad, I don’t hesitate.
That means sometimes our recommendations will be listed foreign exchanges like the NASDAQ in the US or the London Stock Exchange. I show you exactly what you need to know to move on these opportunities. And I explain any additional risks involved.
In short, I give you everything you need to make an informed, educated decision with your money. You’re in control. I’m here to provide ideas, insights, research and advice. But you’re in the driving seat and 100% in control.
I’ve known some stocks to ‘pop’ 50% or 100% higher in a day or two. But that’s not really the goal. The goal is to tap into enormous long-term potential. That means being prepared to wait for that potential to deliver.
So, some of the stocks I tip could rocket up within a few weeks. Others could take months.
And some are longer-term plays — typically those that are linked to a bigger or more disruptive idea.
While I’m extremely fastidious in my research, you must understand that not every share I tip will go up (I wish!). Some will go down. That’s the nature of the stock market.
All stock market investing involves risk. There’s no point swerving that. And anyone who tells you otherwise isn’t being honest with you.
The specific risks involved with this kind of approach depend on exactly what stock opportunity I find. This varies depending on exactly what theme I’m looking at. But I will always highlight the risks along with each of my recommendations.
My only brief is to find emerging tech stocks with huge potential. That might be a small-cap stock. Or it could be a bigger mid to large cap. I don’t care. I don’t restrict myself to any one market or size of stock.
That said, when I do tip smaller stocks, you should know they tend to be much riskier than blue chips because they are hyper-sensitive to news and announcements.
The value of these stocks can jump up rapidly but can fall back just as rapidly.
In other words, never invest more than you could comfortably afford to lose on any one recommendation.
I have your best interests at heart because our interests are completely aligned.
I only make money if people subscribe to my newsletter.
People will only subscribe — and stay subscribed — if they like the research and make money from the tips.
If you don’t make money, you will unsubscribe.
If enough people unsubscribe, my newsletter closes…and I lose my job.
Therefore, it’s in my interests to provide excellent research that makes you money!
When you join Exponential Stock Investor, you’ll receive phone access to our member services team, plus an email address where you can ask any questions related to your subscription (although we can’t give personal investment advice).
Be clear: I want this to work for you. I want you to make a ton of money from my stock recommendations.
And I want my service to be easy for you to follow so that it doesn’t take up too much of your time — or fill your head with stress — every time you buy a stock.
Ready to get started?
Click the link now...
(You can review your order before it’s final)